$SIBN News

SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026

Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $25

SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis

SI-BONE Receives FDA Clearance For Its iFuse Granite Onyx System

SI-BONE, Inc. (SIBN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

SI-BONE (SIBN) Q2 2026 Earnings Call Transcript

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

UBS Maintains Buy on SI-BONE, Raises Price Target to $25

Truist Securities Reiterates Buy on SI-BONE, Raises Price Target to $23

TD Cowen Maintains Buy on SI-BONE, Raises Price Target to $20

SI-BONE, Inc. Q2 2026 Earnings Call Summary

SI-BONE, Inc. (SIBN) Q2 2026 Earnings Call Transcript

SI-BONE Inc (SIBN) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...

SI-BONE (NASDAQ:SIBN) Beats EPS and Raises Guidance, But Shares Slip

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

SiBone Q2 Earnings Call Highlights

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance